Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government Policies to Boost Stem Cell R&D - GBI Research Reports

Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government Policies to Boost Stem Cell R&D

Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government Policies to Boost Stem Cell R&D - GBI Research Reports
Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government Policies to Boost Stem Cell R&D
Published Nov 22, 2011
160 pages — Published Nov 22, 2011
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Research, the leading business intelligence provider, has released its latest research Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government Policies to Boost Stem Cell R&D. The report provides an in-depth analysis on global stem cell research and development. The report suggests investment decisions in stem cell research by providing trends and information on pipelines, federal spending, venture capitalist perspective, country regulations, competitive landscape and market potential. It also provides an analysis on the current investments in various stem cell research segments. In addition to this, the report covers market drivers and challenges for stem cell research and development market.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

GBI Research analysis finds that stem cell therapies have immense market potential driven by strong pipeline that caters to high unmet needs. Increasing investment and supportive regulatory environment in key geographies will help the stem cells industry to realize its full potential. Stem cell therapies high market potential is based on their unique ability to offer curative treatment in comparison to the symptomatic treatment offered by conventional treatments. From a commercial perspective, many diseases that arise as a result of irreversible damage to specialized cell types currently have large unmet needs that cannot be served based on conventional pharmaceutical and biotech research. Not serving these unmet needs results in loss of growth opportunities for the pharmaceutical industry. Stem cell research is a technology that has the potential to serve these unmet needs by providing alternatives to conventional pharmaceutical and biotech research which are targeted more at the symptoms than at the cause.

Strategic partnerships between pharmaceutical companies and stem cell research companies are boosting stem cell research and development. Almost 90% of the drugs in clinical trials fail due to factors such as lack of effectiveness and adverse side effects of the drug. Usually animal or tumor cells are being used and this leads to jury-rigged tests. Hence all major pharmaceutical companies are looking forward for new technologies that increase the possibility to launch new therapies in the market place. At present, there has been a spur in investments from pharmaceutical companies into stem cell research through strategic partnerships with stem cell research companies. Major pharmaceutical companies have planned and aligned their objectives to enter the stem cell market in the next 3-5 years, with a few strategic partnerships already formed between pharmaceutical companies and stem cell research based companies. Pharmaceutical companies are also exploring various methods where stem cells could be utilized in drug discovery process to accelerate the discovery of novel drug molecules.

Scope

- Country analysis of regulatory framework, investments, research clusters and overall support including the US, the UK, Germany, France, Japan, China, India, Singapore, Canada, and Australia.
- Investment Analysis in leading geographies.
- In-depth information and analysis on the pipeline products expected to bring a shift to the market positions of the leading manufacturers.
- Market characterization data for stem cell research including population size, market potential, NIH funding, technology adoption framework and business models.
- Key drivers and restraints that have a significant impact on the market.
- Competitive landscape of global stem cell research including benchmarking of the leading companies. The key compa

  
Source:
Document ID
GBIHC150MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents46
  List of Tables71
  List of Figures82
Stem Cell Research Market to 2017 - Introduction102
  GBI Research Report Guidance111
Stem Cell Research Market to 2017- Market Overview128
  Stem Cell Research An Introduction121
  Types of Stem Cell Research122
  Current Utilization of Different Types of Stem Cells141
  Unmet Needs144
    Applications of Stem Cell Research182
Stem Cell Research Market to 2017- Market Characterization2025
  Stem Cell Market An Introduction201
  Market Sizing213
  Therapy Cost241
  Technology Adoption Framework251
  Types of Business Models261
  Market Drivers271
    Immense Market Opportunity for Stem Cell Research for Certain Disorders with High Unmet Need in Terms of Safe and Efficacious Drugs271
    Encouraging Political Environment on Embryonic Stem Cell Research in the US281
    Advances in Induced Pluripotent Stem Cells (iPSC) can Decrease Dependency on Embryonic Stem Cells and Increase the Acceptance of Stem Cell Therapy291
  Market Barriers &Challenges301
    High Cost of Research Demands High Investments in the Stem Cell Research and Development301
    Uncertain Reimbursement Scenario for Stem Cell Therapies Due to High Treatment Cost and Unclear Cost-Benefit Ratio311
    Ethical, Legal and Social Issues Continue to Remain a Challenge Albeit with Reduced Impact321
    Management of Best Scientific Talent for Stem Cell Research Based Companies Remains a Key Area of Focus to Sustain High Quality Research331
  Stem Cell Research and Development - Market Trends341
    Booming Stem Cell Tourism is a Potential Opportunity for Countries to Attract Investments341
    ASLAP Analysis of Stem Cell Tourism351
      The Present Situation351
      Actors361
      Process361
      Learning361
      Actions361
      Performance361
    Federal Funding Support Improves the Stem Cell Research Environment371
    Increasing Entry of Pharmaceutical Companies Boosts Stem Cell Research &Development381
    PESTLE Analysis of Stem Cell Research391
      Political Environment401
      Economic Environment401
      Society401
      Technology401
      Legislation401
      Environment401
    SWOT Analysis of Stem Cell Research &Development411
      Strengths411
      Weakness411
      Opportunities411
      Threats421
  Market Analysis431
    Industry Rivalry441
    Threat of New Entrant441
    Threat of Substitutes441
    Supplier Power441
    Buyer Power441
Stem Cell Research Market to 2017 - Pipeline Analysis4536
  Discovery451
  IND Filed461
  Pre-Clinical463
  Phase I495
  Phase II5422
  Phase III765
Stem Cell Research Market to 2017 - Investment Trends8132
  Investor s Perspective on Stem Cell Research811
    Status of Research821
    Regulatory Position821
    Clinical Development821
    Commercial Models821
    Patent Policy831
  NIH Spending in Stem Cell Research and Development is Increasing and is Supportive831
    NIH Spending by Therapeutic Areas8417
      Segmentation of Funding Received by Therapeutic Areas1011
      Segmentation of Funding Received by Therapeutic Areas in 20091021
      Segmentation of Funding Received by Therapeutic Areas in 20101031
      Segmentation of Funding Mechanisms by Value in 20091042
      Segmentation of Funding Mechanisms by Value in 20101061
      Segmentation by Total Value of Therapeutic Areas in 20091071
      Segmentation by Total Value of Therapeutic Areas in 20101081
      Segmentation by Total Value of the Funding Mechanisms in 2009 and 20101091
    High Budget Projects Funded by NIH1101
  BBSRC Funding in Stem Cell Research1112
Stem Cell Research Market to 2017 - Geographical Trends11318
  Stem Cell Companies by Geographic Regions1132
  The US1151
  The UK1161
  China1171
  Netherlands1181
  Singapore1191
  South Korea1201
  Japan1211
  India1221
  Sweden1231
  Denmark1241
  France1251
  Germany1261
  Israel1271
  Australia1281
  Canada1291
  Czech Republic1301
Stem Cell Research Market to 2017 - Mergers and Acquisitions1319
  Mergers and Acquisitions1311
    Overview1311
    Segmentation by Type1321
      Segmentation of Deal Value1321
      Segmentation of Deal Number1331
    Segmentation by Region1341
      Segmentation of Deal Value1341
      Segmentation of Deal Number1351
  Licensing Agreements and Co-Development1361
    Segmentation by Region1361
      Segmentation of Deal Value1361
      Segmentation of Deal Number1371
    Segmentation by Deal Type1381
      Segmentation of Deal Value1381
      Segmentation of Deals Number1391
Stem Cell Research Market to 2017 - Company Profiles14014
  Aastrom Biosciences1401
  Athersys Inc.1411
  Osiris Therapeutics1421
  Bioheart1431
  Aldagen1441
  Mesoblast1451
  Geron1461
  Advanced Cell Technology1471
  Cytori Therapeutics1481
  Pluristem Therapeutics1491
  Medistem1501
  NeoStem1511
  Helix Therapeutics1521
  StemCells Inc.1531
Stem Cell Research Market to 2017- University Profiles1542
  University of California, San Francisco1541
  University of Washington1551
Stem Cell Research Market to 2017 - Conclusion1561
Stem Cell Research Market to 2017- Appendix1574
  Market Definitions1571
  Abbreviations1571
  Methodology1574
    Coverage1571
    Secondary Research1581
    Primary Research1581
      Market Characterization1591
      Investment Trends1591
      Pipeline Analysis1591
      Mergers and Acquisitions1591
      Geographical Trends1591
      Company Profiles1591
    Expert Panels1601
  Contact Us1601
  Disclaimer1601
  Sources1601

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government Policies to Boost Stem Cell R&D" Nov 22, 2011. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Stem-Cell-Research-Market-to-2017-Strong-Pipeline-High-Unmet-Needs-in-Chronic-Diseases-and-Favorable-Government-Policies-to-Boost-Stem-Cell-R-D-2115-305>
  
APA:
GBI Research Reports. (2011). Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government Policies to Boost Stem Cell R&D Nov 22, 2011. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Stem-Cell-Research-Market-to-2017-Strong-Pipeline-High-Unmet-Needs-in-Chronic-Diseases-and-Favorable-Government-Policies-to-Boost-Stem-Cell-R-D-2115-305>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.